-
Je něco špatně v tomto záznamu ?
Cognitive impairment and structural brain changes in patients with clinically isolated syndrome at high risk for multiple sclerosis
E. Hynčicová, M. Vyhnálek, A. Kalina, L. Martinkovič, T. Nikolai, J. Lisý, J. Hort, E. Meluzínová, J. Laczó,
Jazyk angličtina Země Německo
Typ dokumentu časopisecké články
Grantová podpora
NT12385
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
ProQuest Central
od 1997-04-01 do 2017-12-31
Medline Complete (EBSCOhost)
od 2000-01-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 1997-04-01 do 2017-12-31
- MeSH
- atrofie MeSH
- demyelinizační nemoci komplikace diagnostické zobrazování psychologie MeSH
- dospělí MeSH
- kognitivní dysfunkce diagnostické zobrazování etiologie MeSH
- lidé MeSH
- magnetická rezonanční tomografie MeSH
- mozek diagnostické zobrazování MeSH
- neuropsychologické testy MeSH
- počítačové zpracování obrazu MeSH
- posuzování pracovní neschopnosti MeSH
- prognóza MeSH
- progrese nemoci MeSH
- rizikové faktory MeSH
- velikost orgánu MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
Patients with clinically isolated syndrome (CIS), unlike those with multiple sclerosis (MS), have a selective cognitive impairment which is not consistently related to structural brain changes. Our objective was to characterize a profile of cognitive impairment and its association with structural brain changes in patients with CIS who are at high risk of developing MS. Patients with CIS at high risk for MS on interferon-beta (n = 51) and age-, gender-, and education-matched controls (n = 44) underwent comprehensive neuropsychological testing and MRI brain scan with voxel-based morphometry. The CIS group had lower cognitive performance in verbal and nonverbal memory, information processing speed/attention/working memory, and executive and visuo-spatial functions compared to controls (p ≤ 0.040). Lower cognitive performance was present in 18-37 and 14-26% of patients with CIS at high risk for MS depending on the criteria used. Brain volume was reduced predominantly in fronto-temporal regions and the thalamus in the CIS group (p ≤ 0.019). Cognitive performance was not associated with structural brain changes except for the association between worse visuo-spatial performance and lower white matter volume in the CIS group (β = 0.29; p = 0.042). Our results indicated that patients with CIS at high risk for MS may have a pattern of lower cognitive performance and regional brain atrophy similar to that found in patients with MS. Lower cognitive performance may be present in up to one-third of patients with CIS at high risk for MS, but, unlike patients with MS, variability in their cognitive performance may lead to a lack of consistent associations with structural brain changes.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17023402
- 003
- CZ-PrNML
- 005
- 20181018154636.0
- 007
- ta
- 008
- 170720s2017 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00415-016-8368-9 $2 doi
- 035 __
- $a (PubMed)28028623
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Hynčicová, Eva $u Department of Neurology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, V Úvalu 84, 150 06, Prague 5, Czech Republic.
- 245 10
- $a Cognitive impairment and structural brain changes in patients with clinically isolated syndrome at high risk for multiple sclerosis / $c E. Hynčicová, M. Vyhnálek, A. Kalina, L. Martinkovič, T. Nikolai, J. Lisý, J. Hort, E. Meluzínová, J. Laczó,
- 520 9_
- $a Patients with clinically isolated syndrome (CIS), unlike those with multiple sclerosis (MS), have a selective cognitive impairment which is not consistently related to structural brain changes. Our objective was to characterize a profile of cognitive impairment and its association with structural brain changes in patients with CIS who are at high risk of developing MS. Patients with CIS at high risk for MS on interferon-beta (n = 51) and age-, gender-, and education-matched controls (n = 44) underwent comprehensive neuropsychological testing and MRI brain scan with voxel-based morphometry. The CIS group had lower cognitive performance in verbal and nonverbal memory, information processing speed/attention/working memory, and executive and visuo-spatial functions compared to controls (p ≤ 0.040). Lower cognitive performance was present in 18-37 and 14-26% of patients with CIS at high risk for MS depending on the criteria used. Brain volume was reduced predominantly in fronto-temporal regions and the thalamus in the CIS group (p ≤ 0.019). Cognitive performance was not associated with structural brain changes except for the association between worse visuo-spatial performance and lower white matter volume in the CIS group (β = 0.29; p = 0.042). Our results indicated that patients with CIS at high risk for MS may have a pattern of lower cognitive performance and regional brain atrophy similar to that found in patients with MS. Lower cognitive performance may be present in up to one-third of patients with CIS at high risk for MS, but, unlike patients with MS, variability in their cognitive performance may lead to a lack of consistent associations with structural brain changes.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a atrofie $7 D001284
- 650 _2
- $a mozek $x diagnostické zobrazování $7 D001921
- 650 _2
- $a kognitivní dysfunkce $x diagnostické zobrazování $x etiologie $7 D060825
- 650 _2
- $a demyelinizační nemoci $x komplikace $x diagnostické zobrazování $x psychologie $7 D003711
- 650 _2
- $a posuzování pracovní neschopnosti $7 D004185
- 650 _2
- $a progrese nemoci $7 D018450
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a počítačové zpracování obrazu $7 D007091
- 650 _2
- $a magnetická rezonanční tomografie $7 D008279
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a neuropsychologické testy $7 D009483
- 650 _2
- $a velikost orgánu $7 D009929
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a rizikové faktory $7 D012307
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Vyhnálek, Martin $u Department of Neurology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, V Úvalu 84, 150 06, Prague 5, Czech Republic. International Clinical Research Center, St. Anne's University Hospital Brno, Pekarska 53, 656 91, Brno, Czech Republic.
- 700 1_
- $a Kalina, Adam $u Department of Neurology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, V Úvalu 84, 150 06, Prague 5, Czech Republic.
- 700 1_
- $a Martinkovič, Lukáš $u Department of Neurology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, V Úvalu 84, 150 06, Prague 5, Czech Republic.
- 700 1_
- $a Nikolai, Tomáš $u Department of Neurology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, V Úvalu 84, 150 06, Prague 5, Czech Republic. International Clinical Research Center, St. Anne's University Hospital Brno, Pekarska 53, 656 91, Brno, Czech Republic.
- 700 1_
- $a Lisý, Jiří $u Department of Radiology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, V Uvalu 84, 150 06, Prague 5, Czech Republic.
- 700 1_
- $a Hort, Jakub $u Department of Neurology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, V Úvalu 84, 150 06, Prague 5, Czech Republic. International Clinical Research Center, St. Anne's University Hospital Brno, Pekarska 53, 656 91, Brno, Czech Republic.
- 700 1_
- $a Meluzínová, Eva $u Department of Neurology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, V Úvalu 84, 150 06, Prague 5, Czech Republic.
- 700 1_
- $a Laczó, Jan $u Department of Neurology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, V Úvalu 84, 150 06, Prague 5, Czech Republic. jan.laczo@lfmotol.cuni.cz. International Clinical Research Center, St. Anne's University Hospital Brno, Pekarska 53, 656 91, Brno, Czech Republic. jan.laczo@lfmotol.cuni.cz.
- 773 0_
- $w MED00002835 $t Journal of neurology $x 1432-1459 $g Roč. 264, č. 3 (2017), s. 482-493
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28028623 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170720 $b ABA008
- 991 __
- $a 20181018155137 $b ABA008
- 999 __
- $a ok $b bmc $g 1239083 $s 984315
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 264 $c 3 $d 482-493 $e 20161227 $i 1432-1459 $m Journal of neurology $n J Neurol $x MED00002835
- GRA __
- $a NT12385 $p MZ0
- LZP __
- $a Pubmed-20170720